| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679640 | Thrombosis Research | 2018 | 6 Pages |
Abstract
In routine practice, the effectiveness and safety of rivaroxaban versus warfarin in VTE patients with a known PHS appears to be similar to that observed in the EINSTEIN trial program.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Craig I. Coleman, Alexander G.G. Turpie, Thomas J. Bunz, William L. Baker, Jan Beyer-Westendorf,